The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial

Clicks: 257
ID: 272387
2015
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In immunocompromised patients, acute respiratory failure (ARF) is associated with high mortality, particularly when invasive mechanical ventilation (IMV) is required. In patients with severe hypoxemia, high-flow nasal oxygen (HFNO) therapy has been used ...
Reference Key
azoulay2015criticalthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Virginie Lemiale, Djamel Mokart, Julien Mayaux, Jérôme Lambert, Antoine Rabbat, Alexandre Demoule, Elie Azoulay;Virginie Lemiale;Djamel Mokart;Julien Mayaux;Jérôme Lambert;Antoine Rabbat;Alexandre Demoule;Elie Azoulay;
Journal critical care
Year 2015
DOI
10.1186/s13054-015-1097-0
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629403/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male aged middle aged Randomized Controlled Trial Multicenter Study multicenter studies as topic intensive care units oxygen inhalation therapy / methods* elie azoulay respiratory insufficiency / drug therapy* virginie lemiale oxygen / therapeutic use pmid:26521922 pmc4629403 doi:10.1186/s13054-015-1097-0 djamel mokart catheters / statistics & numerical data* hypoxia / drug therapy* immunocompromised host / drug effects* masks / statistics & numerical data* oxygen / administration & dosage* oxygen inhalation therapy / adverse effects

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.